RT Journal Article SR Electronic T1 Age-Specific Rates of Onset of Cannabis Use in Mexico JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.11.30.20241463 DO 10.1101/2020.11.30.20241463 A1 Mauricio López-Méndez A1 Angélica Ospina-Escobar A1 Rowan Iskandar A1 Fernando Alarid-Escudero YR 2020 UL http://medrxiv.org/content/early/2020/12/02/2020.11.30.20241463.abstract AB Background Over the previous two decades, the prevalence of cannabis use has risen among the population in Mexico.Aims To estimate the sex- and age-specific rates of onset of cannabis use over time.Design Time-to-event flexible parametric models with spline specifications of the hazard function. Stratified analysis by sex, and control for temporal trends by year of data collection or decennial birth-cohort.Setting Mexico.Participants Pooled sample of 141,342 respondents aged between 12 and 65 years from five nationally representative cross-sectional surveys, the Mexican National Surveys of Addictions (1998, 2002, 2008, 2012) and the Mexican National Survey on Drugs, Alcohol, and Tobacco Consumption (2016).Measurements We estimated age-specific rates of onset of cannabis as the conditional rate of consuming cannabis for the first time at a specific age.Findings Age-specific rates of onset of cannabis use per 1,000 individuals increased over time for both females and males. Peak rates per 1,000 ranged from 0.935 (95%CI= [0.754,1.140]) in 1998, to 5.390 (95%CI= [4.910,5.960]) in 2016 for females; and from 7.510 (95%CI= [5.516, 10.355]) in 1998, to 26.100 (95%CI= [23.162,30.169]) in 2016 for males. Across decennial birth-cohorts, peak rates of onset of cannabis use per 1,000 individuals for females ranged from 0.342 (95%CI= [0.127,0.898]) for those born in the 1930s, to 14.600 (95%CI= [13.200,16.100]) for those born in the 1990s; and for males, from 4.900 (95%CI= [0.768, 7.947]) for those born in the 1930s, to 38.700 (95%CI= [32.553,66.341]) for those born in the 1990s.Conclusion Rates of onset of cannabis use for males are higher than for females; however, the change across recent cohorts of the rates of onset has increased at a faster rate among females. Our findings can inform and improve the implementation of policies around cannabis use by identifying subpopulations by age, sex, and birth-cohort that are at the highest risk of initiating cannabis consumption.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a Scholarship from the Framework in Global Health Scholarship Program as part of the doctoral program of Mauricio Lopez Mendez at Brown University. Dr. Alarid-Escudero was supported by two grants from the National Cancer Institute at the National Institutes of Health (grant number U01-CA-199335 and U01-CA-253913) as part of the Cancer Intervention and Surveillance Modeling Network (CISNET), a grant from the Open Society Foundations (OSF) and a grant from the Gordon and Betty Moore Foundation. The funding agencies had no role in the design of the study, interpretation of results, or writing of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval was not necessary since the study does not involve human subjects research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is publicly availably and maintained for public access by the Government of Mexico. Modeling and statistical analysis will be made available in a public Github repository once the manuscript is submitted for review by a journal. https://encuestas.insp.mx/ena/encodat2017.php